ARCHIVES

R.S.K. Young Quits As FDA Oncology Group Leader

This article is from The Cancer Letter archive.

Vol. 06 No. 28 | July 11, 1980

Download PDF Visit The Full Archive

Related Articles

NY Federal Court Rules Against Myriad, Finding Patents On Genes Unlawful.

April 2, 2010

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

BRCA1 and BRCA2 Mutations Linked To Higher Survival

January 27, 2012

NIH Revises Application Receipt Dates

November 22, 1985

Crout, Finkel Replaced at FDA; Hayes Combine Biologics, Drugs

April 2, 1982

NCI CTEP Approved Trials For the Month of February

February 22, 2013